
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <channel>
        <title>Latest articles by James G. Dickinson from Medical Marketing and Media</title>
        <link>http://www.mmm-online.com/james-g-dickinson/author/79/</link>
        <description>Latest articles by James G. Dickinson from Medical Marketing and Media</description>
        <itunes:author>MMM</itunes:author>
        <itunes:subtitle></itunes:subtitle>
        <itunes:summary></itunes:summary>
        <itunes:owner>
            <itunes:name></itunes:name>
            <itunes:email>mmmsubs@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="BUSINESS">
            <itunes:category text="BUSINESS NEWS" /> 
        </itunes:category> 
        <itunes:image href='http://media.haymarketmedia.com/images/32/MMM_logo_28402_31022.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
  
        <item>
          <title>As I See It: Activism and the FDA</title>
          <description>Appendages of the HHS secretary&apos;s apron strings, FDA commissioners must toe the &quot;party line&quot;</description>
          <link>http://www.mmm-online.com/as-i-see-it-activism-and-the-fda/article/290095/</link>
          <pubDate>Wed, 01 May 2013 04:00:00 GMT</pubDate>
          <itunes:summary>Appendages of the HHS secretary&apos;s apron strings, FDA commissioners must toe the &quot;party line&quot;</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>FDA: Pradaxa fell prey to &quot;stimulated reporting&quot;</title>
          <description>FDA drug safety officials say that an influx of numerous bleeding reports associated with Boehringer Ingelheim&apos;s blood thinner Pradaxa (dabigatran) is a case of &quot;stimulated reporting&quot;</description>
          <link>http://www.mmm-online.com/fda-pradaxa-fell-prey-to-stimulated-reporting/article/290097/</link>
          <pubDate>Wed, 01 May 2013 04:00:00 GMT</pubDate>
          <itunes:summary>FDA drug safety officials say that an influx of numerous bleeding reports associated with Boehringer Ingelheim&apos;s blood thinner Pradaxa (dabigatran) is a case of &quot;stimulated reporting&quot;</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>New approval paths needed: report</title>
          <description>Organization including the Pew Charitable Trusts are voicing basic suppor for FDA&apos;s efforts to develop an alternative approval pathway for certain drugs</description>
          <link>http://www.mmm-online.com/new-approval-paths-needed-report/article/290100/</link>
          <pubDate>Wed, 01 May 2013 04:00:00 GMT</pubDate>
          <itunes:summary>Organization including the Pew Charitable Trusts are voicing basic suppor for FDA&apos;s efforts to develop an alternative approval pathway for certain drugs</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>&quot;Conditional approval&quot; draws dissent</title>
          <description>The idea of scaling back premarket clinical trials comes under fire</description>
          <link>http://www.mmm-online.com/conditional-approval-draws-dissent/article/285618/</link>
          <pubDate>Mon, 01 Apr 2013 04:00:00 GMT</pubDate>
          <itunes:summary>The idea of scaling back premarket clinical trials comes under fire</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Drug quality is FDA&apos;s top 2013 priority: Hamburg </title>
          <description>FDA commissioner Margaret Hamburg is urging the pharmaceutical industry to improve manufacturing quality</description>
          <link>http://www.mmm-online.com/drug-quality-is-fdas-top-2013-priority-hamburg/article/285617/</link>
          <pubDate>Mon, 01 Apr 2013 04:00:00 GMT</pubDate>
          <itunes:summary>FDA commissioner Margaret Hamburg is urging the pharmaceutical industry to improve manufacturing quality</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>FDA mulls fast approval for unmet-needs drugs</title>
          <description>FDA is exploring an alternative drug-approval pathway for drugs intended to address unmet medical needs by &quot;limited use&quot; approvals.</description>
          <link>http://www.mmm-online.com/fda-mulls-fast-approval-for-unmet-needs-drugs/article/281296/</link>
          <pubDate>Fri, 01 Mar 2013 05:00:00 GMT</pubDate>
          <itunes:summary>FDA is exploring an alternative drug-approval pathway for drugs intended to address unmet medical needs by &quot;limited use&quot; approvals.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Innovator risks over generic warnings</title>
          <description>The Alabama Supreme Court ruled that a man who claims he was injured by a generic version of Pfizer&apos;s Reglan can sue the innovator company.</description>
          <link>http://www.mmm-online.com/innovator-risks-over-generic-warnings/article/281298/</link>
          <pubDate>Fri, 01 Mar 2013 05:00:00 GMT</pubDate>
          <itunes:summary>The Alabama Supreme Court ruled that a man who claims he was injured by a generic version of Pfizer&apos;s Reglan can sue the innovator company.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>As I See It: FDA and the First Amendment</title>
          <description>FDA has never won a First Amendment case, and its string of losses led it to bring this one under false colors</description>
          <link>http://www.mmm-online.com/as-i-see-it-fda-and-the-first-amendment/article/277305/</link>
          <pubDate>Fri, 01 Feb 2013 05:00:00 GMT</pubDate>
          <itunes:summary>FDA has never won a First Amendment case, and its string of losses led it to bring this one under false colors</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>FDA chief cites the need for more collaboration</title>
          <description>FDA commissioner Margaret Hamburg says that if academia, industry, government scientists and regulators could come together more in pre-competitive collaboration it could get more done</description>
          <link>http://www.mmm-online.com/fda-chief-cites-the-need-for-more-collaboration/article/277308/</link>
          <pubDate>Fri, 01 Feb 2013 05:00:00 GMT</pubDate>
          <itunes:summary>FDA commissioner Margaret Hamburg says that if academia, industry, government scientists and regulators could come together more in pre-competitive collaboration it could get more done</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Use jail to fight fraud: FDA lawyer</title>
          <description>FDA deputy chief counsel for litigation Eric Blumberg told a December conference that &quot;Money is clearly not doing the job...We need to employ a &apos;bigger hammer,&apos; to send people to jail.&quot;</description>
          <link>http://www.mmm-online.com/use-jail-to-fight-fraud-fda-lawyer/article/277312/</link>
          <pubDate>Fri, 01 Feb 2013 05:00:00 GMT</pubDate>
          <itunes:summary>FDA deputy chief counsel for litigation Eric Blumberg told a December conference that &quot;Money is clearly not doing the job...We need to employ a &apos;bigger hammer,&apos; to send people to jail.&quot;</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
      </channel>
    </rss>  
  